Certara Launches Its Simcyp In Vitro Data Analysis Toolkit

July 30, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

This new standalone solution is designed to meet the needs of early-stage drug discovery and development researchers.

Certara®, the global biosimulation technology-enabled drug development company, announced the launch of its Simcyp In Vitro (Data) Analysis (SIVA) Toolkit, version 1.0. The SIVA Toolkit is designed to enable the analysis of complex in vitro studies, including those with whole cells, tissue samples and solid dosage forms. It combines model-based data analysis approaches to assess the metabolism, transport or dissolution/solubility of drugs with optimization algorithms in a statistical environment. This approach ensures that users do not need to have extensive modeling or statistical experience to use the toolkit.

 

 

Read the full release here.

 

Related Content:

News